FDA Drug Application (020228) for ATROVENT by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number020228
Product Number001
FormSOLUTION;INHALATION
Dosage0.02% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameATROVENT
Active IngredientIPRATROPIUM BROMIDE

Active IngredientCount
List of drugs with Active Ingredient IPRATROPIUM BROMIDE8


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM